• AstraZeneca paused its coronavirus vaccine trials
• US equities try to rebound from a US-led tech rout
European indices ended higher, erasing previous sessions losses as the tech sell-off in the US slowed down. Still, sentiment was hit by the possibility that AstraZeneca Covid-19 vaccine could be delayed after a person participating in one of the studies got sick. Stat News reported that the patient had a serious neurological symptom but he's improving and could be discharge from hospital today. Tomorrow markets’ attention will focus on the ECB monetary policy decision as investors will be looking for further hints on when more stimulus will be added through the pandemic emergency purchase programme. During today's session DAX 30 rose 2.1%, CAC 40 gained 1.6% and FTSE 100 finished 1.62% higher.
Gold prices rebounded to touch a near one-week high of $1,949 an ounce while silver price is approaching $27 resistance level, amid a slightly weaker dollar. WTI crude prices rose more than 4% to trade around $38.3 a barrel, while Brent crude futures gained more than 3.4% to trade around $41.10 a barrel, partially erasing some of the previous session’s heavy losses. Oil traders now await the API report which will be released in the evening.
